Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, giving promising developments across several health-related and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, a lot more reliable option for therapeutic use,